Market Tracker

09/17 5:16pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

During the Trading Day
7.56 +0.40 / +5.59%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.56 0.00 / 0.00%
 
Volume: 1.5K
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close7.16
Today’s open7.40
Day’s range7.17 - 7.71
Volume378,588
Average volume (3 months)508,474
Market cap$272.4M
Dividend yield--
Data as of 3:59pm ET, 09/17/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+20.71%
Earnings growth (next 5 years)+3.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.07+2.58%
THLDThreshold Pharmaceut...+0.06+1.30%
AGTCApplied Genetic Tech...+0.06+0.36%
SVASinovac Biotech Ltd+0.07+1.41%
Data as of 3:59pm ET, 09/17/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts